A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study ...

Takeda (TSE:4502/NYSE:TAK) today announced that applications are now open for its Innovators in Science Award. This prestigious global award, originally launched in 2016, celebrates groundbreaking ...

The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...

The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking ...

Syndeio Biosciences today announced its launch to pioneer precision neurotherapeutics focused on repairing and enhancing synaptic function in central nervous system (CNS) diseases. The company’s ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...

NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the “Company”) today announced ...

Detailed price information for Roche Holding Ltd (RHHVF) from The Globe and Mail including charting and trades.

Patients with eosinophilic esophagitis face significant economic burdens, according to a pair of presentations at Digestive ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...